Out-of-range INR results lead to increased health-care utilization in four large anticoagulation clinics.
Geoffery D BarnesXiaokui GuEva Kline-RogersChristopher GravesEric PurollKevin TownsendEllen McMahonTerri CraigJames B FroehlichPublished in: Research and practice in thrombosis and haemostasis (2018)
We quantified the amount of extra anticoagulation staff effort required to manage warfarin-treated patients who experience a single OOR INR value without bleeding or thromboembolic complications, which leads to higher healthcare utilization costs.